Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Suppression of IL-10 production by calcitriol in patients with multiple sclerosis.
Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis.
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
How big is the myelinating orchestra? Cellular diversity within the oligodendrocyte lineage: facts and hypotheses.
The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration.
Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Treatment Adherence and Transitioning Youth in Pediatric Multiple Sclerosis.
Tysabri Review Launched in Europe
Differential microRNA expression in blood in multiple sclerosis.
New drug for relapsing multiple sclerosis.
An exploratory study of decision making by informal caregivers of individuals with multiple sclerosis.
Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells.
Virus-induced CD8+ T cells accelerate the onset of experimental autoimmune encephalomyelitis: Implications for how viral infections might trigger multiple sclerosis exacerbations.
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review.
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances.
Brain abnormalities in neuromyelitis optica spectrum disorder.
The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
Targeting erythropoietin for chronic neurodegenerative diseases.
Inflammatory demyelinating diseases in children: an update.
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.
Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran.
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination.
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Pages
« first
‹ previous
…
335
336
337
338
339
340
341
342
343
…
next ›
last »